Top

Journal of Cancer Survivorship

Published in:

Open Access 13-01-2023 | Tinnitus | Review

The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review

Authors: Olivia R. Phillips, David M. Baguley, Stephanie E. Pearson, Michael A. Akeroyd

Published in: Journal of Cancer Survivorship | Issue 1/2023

Abstract

Purpose

To elucidate the long-term impacts of hearing loss, tinnitus and balance in people living with and beyond cancer (LWBC) treated with platinum-based chemotherapy (PBCT).

Methods

A literature search was conducted between March and June 2022 using PubMed, Web of Science and Google Scholar. Full-text papers in English were included. Articles explored the impacts of hearing loss, tinnitus and balance and discussed them in the context of treatment. If PBCT was used in conjunction with other treatments, the article was included. There were no constraints on age, cancer type, publication date, location, study design or data type. Sixteen studies and two reviews were included.

Results

Hearing loss and tinnitus can cause communication difficulties and subsequent social withdrawal. There were deficits in cognition, child development and educational performance. Employment and the ease of everyday life were disrupted by hearing loss and tinnitus, whereas poor balance interfered with walking and increased the risk of falls. Depression and anxiety were related to ototoxicity. Most notable were the differing mindsets experienced by adults LWBC with ototoxicity. There was evidence of inadequate monitoring of ototoxicity by clinicians and a lack of communication between clinicians and patients about ototoxicity as a side effect.

Conclusions

Ototoxicity has a negative long-term impact on multiple areas of life for adults and children LWBC. This can compromise their quality of life.

Implications for cancer survivors

Increased awareness, monitoring and education surrounding these issues may lead to earlier intervention and better management of ototoxicity, enhancing the quality of life of people LWBC.

Available only for authorised users

World Health Organisation, ‘All cancers’, 2020, Accessed: Aug. 30, 2022. [Online]. Available: https://gco.iarc.fr/today

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. https://doi.org/10.3322/CAAC.21708.CrossRefPubMed

Pearson SE, Taylor J, Patel P, Baguley DM. Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review. Int J Audiol. 2019;58(11):685–95. https://doi.org/10.1080/14992027.2019.1660918.CrossRefPubMed

D. Teoli and A. Bhardwaj, ‘Quality Of Life’, StatPearls, Mar. 2022, Accessed: Aug. 30, 2022. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK536962/

M. Kolator, P. Kolator, and T. Zatoński, ‘Assessment of quality of life in patients with laryngeal cancer: a review of articles’, Advances in Clinical and Experimental Medicine, vol. 27, no. 5, pp. 711–715, 2018, Accessed: Aug. 30, 2022. [Online]. Available: https://advances.umw.edu.pl/pdf/2018/27/5/711.pdf

C. Rabik and M. Dolan, ‘Molecular mechanisms of resistance and toxicity associated with platinating agents’, Elsevier, 2007, Accessed: Aug. 30, 2022. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S030573720600171X?casa_token=uNrzPzPpR4QAAAAA:w6oh7wiwczttn92YC7TxLhCX1WjjKPPQmOUuX7o1oF_eNCV7-xjiEsXjEO3Z2I_iiHsc-eMT

C. J. Kros and P. S. Steyger, ‘Aminoglycoside- and cisplatin-induced ototoxicity: mechanisms and otoprotective strategies’, Cold Spring Harb Perspect Med, vol. 9, no. 11, Nov. 2019, https://doi.org/10.1101/CSHPERSPECT.A033548.

R. Frisina, H. Wheeler, … S. F.-J. of C., and undefined 2016, ‘Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer’, ncbi.nlm.nih.gov, Accessed: Aug. 30, 2022. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019759/

J. Schacht, A. Talaska, L. R.-T. A. Record, and undefined 2012, ‘Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention’, Wiley Online Library, vol. 295, no. 11, pp. 1837–1850, Nov. 2012, https://doi.org/10.1002/ar.22578.

10.

J. Paken, C. D. Govender, M. Pillay, and V. Sewram, ‘Cisplatin-associated ototoxicity: a review for the health professional. J Toxicol vol. 2016, 2016, https://doi.org/10.1155/2016/1809394.

11.

Landier W. Ototoxicity and cancer therapy. Cancer. 2016;122(11):1647–58. https://doi.org/10.1002/CNCR.29779.CrossRefPubMed

12.

Bhandare N, Antonelli PJ, Morris CG, Malayapa RS, Mendenhall WM. ‘Ototoxicity after radiotherapy for head and neck tumors. Int J Radiation Oncol Biol Phys. 2007;67(2):469–79. https://doi.org/10.1016/J.IJROBP.2006.09.017.CrossRef

13.

G. Cianfrone et al., ‘Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide’, 2011.

14.

G. Al-Malky, ‘Audiological monitoring in ototoxicity-are we doing enough?’, ENT and Audiology News, 2016. www.ear.ucl.ac.uk/training/lecturers/al-malky. (accessed Aug. 30, 2022).

15.

Shukla A, et al. Hearing loss, loneliness, and social isolation: a systematic review. Otolaryngology-Head and Neck Surgery. 2020;2020(5):622–33. https://doi.org/10.1177/0194599820910377.CrossRef

16.

Lawrence BJ, Jayakody DMP, Bennett RJ, Eikelboom RH, Gasson N, Friedland PL. Hearing loss and depression in older adults: a systematic review and meta-analysis. Gerontologist. 2020;60(3):e137–54. https://doi.org/10.1093/GERONT/GNZ009.CrossRefPubMed

17.

Livingston G, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020;396(10248):413–46. https://doi.org/10.1016/S0140-6736(20)30367-6/ATTACHMENT/CEE43A30-904B-4A45-A4E5-AFE48804398D/MMC1.PDF.CrossRef

18.

Ziai K, Moshtaghi O, Mahboubi H, Djalilian HR. Tinnitus patients suffering from anxiety and depression: a review. Int Tinnitus J. 2017;21(1):68–73. https://doi.org/10.5935/0946-5448.20170013.CrossRefPubMed

19.

Crönlein T, Langguth B, Pregler M, Kreuzer PM, Wetter TC, Schecklmann M. Insomnia in patients with chronic tinnitus: cognitive and emotional distress as moderator variables. J Psychosom Res. 2016;83:65–8. https://doi.org/10.1016/J.JPSYCHORES.2016.03.001.CrossRefPubMed

20.

Erlandsson SI, Hallberg LRM. Prediction of quality of life in patients with tinnitus. Br J Audiol. 2011;34(1):11–9. https://doi.org/10.3109/03005364000000114.CrossRef

21.

Baguley DM, Prayuenyong P. ‘Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy. Cancer Chemotherapy Pharmacol. 2019;85(2):245–50. https://doi.org/10.1007/S00280-019-04012-Z.CrossRef

22.

P. Prayuenyong et al., ‘Vestibulotoxicity associated with platinum-based chemotherapy in survivors of cancer: a scoping review’, Front Oncol, 2018, Accessed: Aug. 30, 2022. [Online]. Available: https://www.frontiersin.org/articles/https://doi.org/10.3389/fonc.2018.00363/full

23.

P. Stavroulaki, N. Apostolopoulos, … J. S.-I. journal of, and undefined 2001, ‘Evoked otoacoustic emissions—an approach for monitoring cisplatin induced ototoxicity in children’, Elsevier, 2001, Accessed: Aug. 30, 2022. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S0165587601004554?casa_token=lvMjLpiLv_kAAAAA:zaffUpOmhuBhsDEOJmOZhgNDqXG59LhvmtlMCxc-1cs8xe-IW5rFpC7LHRH8M5QYA4X4tMnH

24.

A. B. Wang, S. N. Housley, A. M. Flores, S. M. Kircher, E. J. Perreault, and T. C. Cope, ‘A review of movement disorders in chemotherapy-induced neurotoxicity. J Neuroeng Rehabil, vol 18 no. 1 2021, https://doi.org/10.1186/S12984-021-00818-2.

25.

S. Wechsler and L. Wood, ‘The effect of chemotherapy on balance, gait, and falls among cancer survivors: a scoping review’, Rehabilitation Oncology, 2021, Accessed: Aug. 30, 2022. [Online]. Available: https://journals.lww.com/rehabonc/Fulltext/2021/01000/The_Effect_of_Chemotherapy_on_Balance,_Gait,_and.4.aspx?casa_token=dW8mFGdR2osAAAAA:7I8FI19--q_TBAz6-bO7EvoC2Yd39FOcdDmGRgfUOIandGoqv96Z4GQ2CYkS4atW6Jy18MkdYnEQUMLlKzEOZoGRrDQgevM

26.

Khan A, et al. The experience of hearing loss in adult survivors of childhood and young adult cancer: A qualitative study. Cancer. 2020;126(8):1776–83. https://doi.org/10.1002/CNCR.32698.CrossRefPubMed

27.

S. Waissbluth, A. Chuang, … Á. D. V.-I. journal of, and undefined 2018, ‘Long term platinum-induced ototoxicity in pediatric patients’, Elsevier, 2018, Accessed: Aug. 30, 2022. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S0165587618300442?casa_token=cuD38Hp8j4wAAAAA:68B2jfAanjCJbSZyR__S-emNU90rea-buKplSPWDwhTSTPMH9Pb-54NfbBkbmYFOSWeorgAA

28.

Einarsson EJ, et al. Long term hearing degeneration after platinum-based chemotherapy in childhood. Int J Audiol. 2010;49(10):765–71. https://doi.org/10.3109/14992027.2010.485595.CrossRefPubMed

29.

S. E. Pearson, C. Caimino, M. Shabbir, and D. M. Baguley, ‘The impact of chemotherapy-induced inner ear damage on quality of life in cancer survivors: a qualitative study. Journal of Cancer Survivorship 1–12 2021, https://doi.org/10.1007/S11764-021-01089-5/FIGURES/1.

30.

Gilmer Knight KR, Kraemer DF, Neuwelt EA. ‘Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol. 2005;23:8588–96. https://doi.org/10.1200/JCO.2004.00.5355.CrossRef

31.

Aggarwal P, et al. Association of hearing loss and tinnitus symptoms with health-related quality of life among long-term oropharyngeal cancer survivors. Cancer Med. 2022;00:1–15. https://doi.org/10.1002/CAM4.4931.CrossRef

32.

Pearson SE, Taylor J, Hoare DJ, Patel P, Baguley DM. Exploring the experiences of cancer patients with chemotherapy-induced ototoxicity: qualitative study using online health care forums. JMIR Cancer. 2019;5(1):e10883. https://doi.org/10.2196/10883.CrossRefPubMedPubMedCentral

33.

Brinkman TM, et al. Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: results from the St. Jude Lifetime Cohort Study. Cancer. 2015;121(22):4053–61. https://doi.org/10.1002/CNCR.29604.CrossRefPubMed

34.

B. Wilson and D. Tucci, ‘Addressing the global burden of hearing loss’, The Lancet, pp. 945–947, 2021, Accessed: Aug. 30, 2022. [Online]. Available: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00522-5/fulltext

35.

Cacioppo JT, Hawkley LC. Perceived social isolation and cognition. Trends Cogn Sci. 2009;13(10):447–54. https://doi.org/10.1016/J.TICS.2009.06.005.CrossRefPubMedPubMedCentral

36.

Leigh-Hunt N, et al. An overview of systematic reviews on the public health consequences of social isolation and loneliness. Public Health. 2017;152:157–71. https://doi.org/10.1016/J.PUHE.2017.07.035.CrossRefPubMed

37.

Ye X, et al. ‘Effects of providing free hearing aids on multiple health outcomes among middle-aged and older adults with hearing loss in rural China: a randomized controlled trial. BMC Med. 2022;20:1. https://doi.org/10.1186/S12916-022-02323-2.CrossRef

38.

Niemensivu R, Manchaiah V, Roine RP, Kentala E, Sintonen H. Health-related quality of life in adults with hearing impairment before and after hearing-aid rehabilitation in Finland. Int J Audiol. 2015;54(12):967–75. https://doi.org/10.3109/14992027.2015.1077400.CrossRefPubMed

39.

Weinstein BE, Sirow LW, Moser S. Relating hearing aid use to social and emotional loneliness in older adults. Am J Audiol. 2016;25(1):54–61. https://doi.org/10.1044/2015_AJA-15-0055.CrossRefPubMed

40.

Maru D, G. al Malky,. ‘Current practice of ototoxicity management across the United Kingdom (UK). Int J Audiol. 2018;57(76):88. https://doi.org/10.1080/14992027.2018.1460495.CrossRef

41.

Bernstein LJ, McCreath GA, Komeylian Z, Rich JB. Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: a multilevel meta-analysis. Neurosci Biobehav Rev. 2017;83:417–28. https://doi.org/10.1016/J.NEUBIOREV.2017.10.028.CrossRefPubMed

42.

Bass JK, et al. Association of hearing impairment with neurocognition in survivors of childhood cancer. JAMA Oncol. 2020;6(9):1363–71. https://doi.org/10.1001/JAMAONCOL.2020.2822.CrossRefPubMed

43.

J. Schreiber, J. Gurney, S. Palmer, … J. B.-N., and undefined 2014, ‘Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma’, Neuro Oncol, 2014, Accessed: Aug. 30, 2022. [Online]. Available: https://academic.oup.com/neuro-oncology/article-abstract/16/8/1129/1288487

44.

Miaskowski C, et al. Impact of chemotherapy-induced neurotoxicities on adult cancer survivors’ symptom burden and quality of life. J Cancer Surviv. 2018;12(2):234–45. https://doi.org/10.1007/S11764-017-0662-8/TABLES/3.CrossRefPubMed

45.

Al-Khatib T, Cohen N, Carret AS, Daniel S. Cisplatinum ototoxicity in children, long-term follow up. Int J Pediatr Otorhinolaryngol. 2010;74(8):913–9. https://doi.org/10.1016/J.IJPORL.2010.05.011.CrossRefPubMed

46.

Gurney JG, Tersak JM, Ness KK, Landier W, Matthay KK, M. lou Schmidt,. ‘Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children’s Oncology Group. Pediatrics. 2007;120(5):e1229–36. https://doi.org/10.1542/PEDS.2007-0178.CrossRefPubMed

47.

K. Rajput, L. Edwards, P. Brock, … A. A.-I. J. of, and undefined 2020, ‘Ototoxicity-induced hearing loss and quality of life in survivors of paediatric cancer’, Elsevier, 2020, Accessed: Aug. 30, 2022. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S0165587620305449?casa_token=l9Dry7jZDYwAAAAA:4uKPP17NRsqdp4B02ibf6BajfHRoJQjoPnNHHPYFY6-2ywbHnokCmbkW_O8TxiyoNPwOOVms

48.

Russell K, Hudson M, Long A, Cancer SP-, undefined,. ‘Assessment of health-related quality of life in children with cancer: consistency and agreement between parent and child reports. Wiley Online Library. 2006;106(10):2267–74. https://doi.org/10.1002/cncr.21871.CrossRef

49.

Weiss A, et al. Hearing loss and quality of life in survivors of paediatric CNS tumours and other cancers. Qual Life Res. 2019;28(2):515–21. https://doi.org/10.1007/S11136-018-2021-2.CrossRefPubMed

50.

F. H. Bess, J. Dodd-Murphy, and R. A. Parker, ‘Children with minimal sensorineural hearing loss: prevalence... : ear and hearing’, Ear Hear, vol. 19, no. 5, pp. 339–354, 1998, Accessed: Aug. 30, 2022. [Online]. Available: https://journals.lww.com/ear-hearing/Fulltext/1998/10000/Children_with_Minimal_Sensorineural_Hearing_Loss_.1.aspx%23P86?casa_token=s-ULfeSfwaMAAAAA:s3iitScirKX1__z3BbR2UIL_CTIQFEWWy8FWNiljGn-6s5SS52QnBoiV-H81K2NPB6rb5c08cLZ-NJ16NhfKVAIcycT_WAk

51.

Yancey A, Harris MS, Egbelakin A, Gilbert J, Pisoni DB, Renbarger J. Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients. Wiley Online Library. 2012;59(1):144–8. https://doi.org/10.1002/pbc.24138.CrossRef

52.

Niederer D, et al. Functional capacity and fear of falling in cancer patients undergoing chemotherapy. Gait Posture. 2014;39(3):865–9. https://doi.org/10.1016/J.GAITPOST.2013.11.014.CrossRefPubMed

53.

Stone CA, Lawlor PG, Kenny RA. How to identify patients with cancer at risk of falling: a review of the evidence. J Palliat Med. 2011;14(2):221–30. https://doi.org/10.1089/jpm.2010.0326.CrossRefPubMed

54.

Kolb NA, et al. The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling. JAMA Neurol. 2016;73(7):860–6. https://doi.org/10.1001/JAMANEUROL.2016.0383.CrossRefPubMedPubMedCentral

55.

Miaskowski C, et al. Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy. Eur J Oncol Nurs. 2018;32:1–11. https://doi.org/10.1016/J.EJON.2017.10.006.CrossRefPubMed

56.

Korfage IJ, de Koning HJ, Roobol M, Schröder FH, Essink-Bot ML. Prostate cancer diagnosis: the impact on patients’ mental health. Eur J Cancer. 2006;42(2):165–70. https://doi.org/10.1016/J.EJCA.2005.10.011.CrossRefPubMed

57.

T. Wildes, P. Dua, S. Fowler, … J. M.-J. of geriatric, and undefined 2015, ‘Systematic review of falls in older adults with cancer’, Elsevier, 2015, Accessed: Aug. 30, 2022. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S1879406814003518?casa_token=n9oq1NuNWcQAAAAA:NfeEHMe5J_JbV6J_cjEuLs92tVg4IdLw3NTHFhwej6mBS31eeb8apVrvHvZwy5OMzveVRBl4

58.

Brown ECM, Caimino C, Benton CL, Baguley DM. An audit of UK audiological practice in specialist paediatric oncology centres regarding hearing assessment of children at risk of ototoxicity due to chemotherapy. J Laryngol Otol. 2021;135(1):14–20. https://doi.org/10.1017/S0022215121000025.CrossRefPubMed

59.

American Speech-Language-Hearing Association, ‘Audiologic management of individuals receiving cochleotoxic drug Therapy’ 1994, https://doi.org/10.1044/POLICY.GL1994-00003.

60.

M. Sánchez-Canteli, … F. N.-B.-A. de P., and undefined 2021, ‘Ototoxicity in cancer survivors: experience and proposal of a surveillance protocol’, Elsevier, 2021, Accessed: Aug. 30, 2022. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S2341287921001629

61.

Ehlert K, Heinze B, Swanepoel DW. Ototoxicity monitoring in South African cancer facilities: a national survey. South African Journal of Communication Disorders. 2022;69(1):1–10. https://doi.org/10.4102/SAJCD.V69I1.846.CrossRef

Title: The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review
Authors: Olivia R. Phillips
David M. Baguley
Stephanie E. Pearson
Michael A. Akeroyd
Publication date: 13-01-2023
Publisher: Springer US
Keywords: Tinnitus
Cytostatic Therapy
Published in: Journal of Cancer Survivorship / Issue 1/2023
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-022-01314-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Implications for cancer survivors

Please log in to get access to this content

Other articles of this Issue 1/2023

Effectiveness and implementation of models of cancer survivorship care: an overview of systematic reviews

Feasibility and acceptability of home-based strength training in endometrial cancer survivors

Beliefs and interests in physical activity programs of cancer survivors and their romantic partners

A prospective study of lifestyle factors and bone health in breast cancer patients who received aromatase inhibitors in an integrated healthcare setting

Rehabilitation interventions for the management of breast cancer–related lymphedema: developing a patient-centered, evidence-based plan of care throughout survivorship

Self-reported causes of cancer among 6881 survivors with 6 tumour types: results from the PROFILES registry

Keynote webinar | Spotlight on antibody–drug conjugates in cancer